BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 22772764)

  • 1. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children.
    Lundh M; Christensen DP; Damgaard Nielsen M; Richardson SJ; Dahllöf MS; Skovgaard T; Berthelsen J; Dinarello CA; Stevenazzi A; Mascagni P; Grunnet LG; Morgan NG; Mandrup-Poulsen T
    Diabetologia; 2012 Sep; 55(9):2421-31. PubMed ID: 22772764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines.
    Lundh M; Christensen DP; Rasmussen DN; Mascagni P; Dinarello CA; Billestrup N; Grunnet LG; Mandrup-Poulsen T
    Diabetologia; 2010 Dec; 53(12):2569-78. PubMed ID: 20878317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells.
    Larsen L; Tonnesen M; Ronn SG; Størling J; Jørgensen S; Mascagni P; Dinarello CA; Billestrup N; Mandrup-Poulsen T
    Diabetologia; 2007 Apr; 50(4):779-89. PubMed ID: 17265033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.
    Jia H; Pallos J; Jacques V; Lau A; Tang B; Cooper A; Syed A; Purcell J; Chen Y; Sharma S; Sangrey GR; Darnell SB; Plasterer H; Sadri-Vakili G; Gottesfeld JM; Thompson LM; Rusche JR; Marsh JL; Thomas EA
    Neurobiol Dis; 2012 May; 46(2):351-61. PubMed ID: 22590724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein acetylation derepresses Serotonin Synthesis to potentiate Pancreatic Beta-Cell Function through HDAC1-PKA-Tph1 signaling.
    Zhang Y; Wang S; Zhang L; Zhou F; Zhu K; Zhu Q; Liu Q; Liu Y; Jiang L; Ning G; Bi Y; Zhou L; Wang X
    Theranostics; 2020; 10(16):7351-7368. PubMed ID: 32641996
    [No Abstract]   [Full Text] [Related]  

  • 7. Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation.
    Zhang Y; Li M; Wang Y; Liu X; Zhou L; Zhang C; Shao L
    Life Sci; 2020 Sep; 257():118073. PubMed ID: 32663574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
    Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
    PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC1 and HDAC2 regulate anti-inflammatory effects of anesthetic isoflurane in human monocytes.
    Guo X; Deng J; Zheng B; Liu H; Zhang Y; Ying Y; Jia J; Ruan X
    Immunol Cell Biol; 2020 Apr; 98(4):318-331. PubMed ID: 31950542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC inhibitor-mediated beta-cell protection against cytokine-induced toxicity is STAT1 Tyr701 phosphorylation independent.
    Dahllöf MS; Christensen DP; Harving M; Wagner BK; Mandrup-Poulsen T; Lundh M
    J Interferon Cytokine Res; 2015 Jan; 35(1):63-70. PubMed ID: 25062500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC7 is overexpressed in human diabetic islets and impairs insulin secretion in rat islets and clonal beta cells.
    Daneshpajooh M; Bacos K; Bysani M; Bagge A; Ottosson Laakso E; Vikman P; Eliasson L; Mulder H; Ling C
    Diabetologia; 2017 Jan; 60(1):116-125. PubMed ID: 27796421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
    Ashburner BP; Westerheide SD; Baldwin AS
    Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.
    Kikuchi J; Wada T; Shimizu R; Izumi T; Akutsu M; Mitsunaga K; Noborio-Hatano K; Nobuyoshi M; Ozawa K; Kano Y; Furukawa Y
    Blood; 2010 Jul; 116(3):406-17. PubMed ID: 20351311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection.
    Christensen DP; Gysemans C; Lundh M; Dahllöf MS; Noesgaard D; Schmidt SF; Mandrup S; Birkbak N; Workman CT; Piemonti L; Blaabjerg L; Monzani V; Fossati G; Mascagni P; Paraskevas S; Aikin RA; Billestrup N; Grunnet LG; Dinarello CA; Mathieu C; Mandrup-Poulsen T
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1055-9. PubMed ID: 24395784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis.
    Chou DH; Holson EB; Wagner FF; Tang AJ; Maglathlin RL; Lewis TA; Schreiber SL; Wagner BK
    Chem Biol; 2012 Jun; 19(6):669-73. PubMed ID: 22726680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion.
    Remsberg JR; Ediger BN; Ho WY; Damle M; Li Z; Teng C; Lanzillotta C; Stoffers DA; Lazar MA
    Mol Metab; 2017 Jan; 6(1):30-37. PubMed ID: 28123935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory β-cell damage.
    Lindeløv Vestergaard A; Heiner Bang-Berthelsen C; Fløyel T; Lucien Stahl J; Christen L; Taheri Sotudeh F; de Hemmer Horskjær P; Stensgaard Frederiksen K; Greek Kofod F; Bruun C; Adrian Berchtold L; Størling J; Regazzi R; Kaur S; Pociot F; Mandrup-Poulsen T
    PLoS One; 2018; 13(9):e0203713. PubMed ID: 30260972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line.
    Duan HY; Ma D; Zhou KY; Wang T; Zhang Y; Li YF; Wu JL; Hua YM; Wang C
    Chin Med J (Engl); 2017 Jun; 130(11):1352-1360. PubMed ID: 28524836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
    Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
    Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.